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Intracellular calciumThe P2X purinergic receptor sub-family of ligand-gated ion channels are subject to protein kinase
modulation. We have previously demonstrated that P2X4R signaling can be positively regulated by
increasing intracellular cAMP levels. The molecular mechanism underlying this effect was, however,
unknown. The present study initially addressed whether protein kinase A (PKA) activation was required.
Subsequently a mutational approach was utilized to determine which region of the receptor was required for
this potentiation. In both DT-40 3KO and HEK-293 cells transiently expressing P2X4R, forskolin treatment
enhanced ATP-mediated signaling. Speciﬁc PKA inhibitors prevented the forskolin-induced enhancement of
ATP-mediated inward currents in P2X4R expressing HEK-293 cells. To deﬁne which region of the P2X4R was
required for the potentiation, mutations were generated in the cytoplasmic C-terminal tail. It was
determined that a limited region of the C-terminus, consisting of a non-canonical tyrosine based sorting
motif, was required for the effects of PKA. Of note, this region does not harbor any recognizable PKA
phosphorylation motifs, and no direct phosphorylation of P2X4R was detected, suggesting that PKA
phosphorylation of an accessory protein interacts with the endocytosis motif in the C-terminus of the P2X4R.
In support of this notion, using Total Internal Reﬂection Fluorescence Microscopy (TIRF) P2X4-EGFP was
shown to accumulate at/near the plasma membrane following forskolin treatment. In addition, disrupting
the endocytosis machinery using a dominant-negative dynamin construct also prevented the PKA-mediated
enhancement of ATP-stimulated Ca2+ signals. Our results are consistent with a novel mechanism of P2XR
regulation, whereby PKA activity, without directly phosphorylating P2X4R, markedly enhances ATP-
stimulated P2X4R currents and hence cytosolic Ca2+ signals. This may occur at least in part, by altering the
trafﬁcking of a population of P2X4R present at the plasma membrane.P, adenosine 3′,5′-cyclic mono-
P2XR, P2X receptor(s); [Ca2+]i,
5-trisphosphate receptors; PM,
cence Microscopy
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Extracellular adenosine triphosphate (ATP) can act as a signaling
molecule by activating cell surface P2Y and P2X purinoreceptors [1].
Intracellular Ca2+ ([Ca2+]i) changes can be initiated by activation of
Gαq-coupled P2Y receptor (P2YR) or as a result of P2X receptor
(P2XR) activation. In contrast to P2YR, these receptors are non-
selective Ca2+ permeable cation channels [2]. All P2XR are activated
by ATP, but not by UTP [2,3]. To date there have been seven genes
identiﬁed which code for P2XR (P2X1R–P2X7R). These proteins range
in size from 388 to 595 amino acids (rat P2X4R and P2X7R,
respectively) and the sequences are most divergent in the C-terminus
[2].The predicted membrane topology of P2XR differs from other
members of the ligand-gated channel super family. The generally
accepted structural model proposes two transmembrane spanning
domains with a large extracellular region containing the agonist
binding site [4,5]. Both the N- and C-termini project into the cytosol.
The functional P2XR channel is thought to be formed by the
multimerization of three P2X subunits [6]. In turn, ATP is proposed
to bind in an inter-molecular pocket formed between adjacent
subunits coordinated by three conserved lysine residues near the
extracellular ends of the transmembrane spanning domains [2,7]. This
structural model has been largely based on extensive mutagenesis
and structure–function studies. Notably, however, a majority of these
anticipated features have been conﬁrmed by a recent study in which
the crystal structure of a substantial portion of the Zebra ﬁsh P2X4R in
the closed state at 3.5 Å resolution was solved [8,9]. Compounding
P2XR signaling complexity, there is also evidence that many P2XR
subtypes can form functional heteromeric channels [10–14].
P2XR have been shown to be regulated by both protein kinase A
(PKA) and protein kinase C (PKC) activation, suggesting they might
be substrates for phosphorylation [15–18]. Previously our lab has
276 D.A. Brown, D.I. Yule / Biochimica et Biophysica Acta 1803 (2010) 275–287demonstrated that P2X4R but not P2X7R signaling could be aug-
mented by increasing intracellular cAMP levels [19]. The molecular
mechanism was unclear at that time because cAMP acts on multiple
effectors, including PKA and exchange proteins directly activated by
cAMP (EPAC) [20,21]. Conceptually, PKA activation could directly
phosphorylate P2X4R or alternatively might act indirectly by
phosphorylation of an accessory protein. EPAC activation has been
shown to activate the monomeric G protein Rap1, which can in turn
lead to activation of downstream signaling events [20,21].
A principal goal of the present study therefore was to investigate
the mechanism underlying cAMP-mediated enhancement of P2X4R
signaling. The experiments in this study suggest a novel PKA-
dependent mechanism, which does not involve direct phosphoryla-
tion of the P2X4R. Nevertheless, we demonstrate that a limited region
in the P2X4R C-terminus is required for the action of PKA. This region
contains a non-canonical tyrosine based sorting motif, previously
shown to be involved in the retrieval of the receptor from the plasma
membrane (PM) via endocytosis. Our data support the notion that
PKA phosphorylation alters trafﬁcking by modulating endocytosis
of P2X4R such that more functional receptors are present at the
plasma membrane leading to enhanced current and augmented
cytosolic Ca2+ signaling.2. Materials and methods
2.1. PCR and primers
Primers for all constructs were from Integrated DNA Technologies
(Coralville, IA). PCR reactions were performed as previously described
using standard reagents from Invitrogen (Carlsbad, CA) [19]. The
primer sequences are shown in Table 1.2.2. Creation of P2XR constructs
Rat P2X4R cDNA was ampliﬁed by PCR to generate P2X4-EGFP,
P2X4-Δ384-EGFP, P2X4-Δ378-EGFP, and P2X4-AAA-EGFP. HindIII and
SalI restriction sites were incorporated into the oligonucleotides used
for PCR ampliﬁcation (shown in bold, Table 1). The PCR products were
restriction enzyme digested and ligated into pEGFP-N3 at the HindIII
and SalI sites (BD Biosciences Clontech, San Jose, CA). All constructs,
which were veriﬁed by sequencing resulted in fusion proteins with
EGFP at the C-terminus of the rat P2X4R. Human P2X1R cDNA (kindly
provided by R.A. North, University of Manchester, UK) was ampliﬁed
by PCR to generate P2X4-C-P2X1-EGFP. AclI and SalI restriction sites
were incorporated into the oligonucleotides used for PCR ampliﬁca-
tion (shown in bold, Table 1). The PCR products were digested with
restriction enzyme and ligated into P2X4-EGFP at the AclI and SalI
sites. This construct, creates a chimeric P2X4R with the C-terminus of
P2X1R which is C-terminally tagged with EGFP. Rat P2X4-AAA-EGFP
cDNAwas ampliﬁed by PCR to generate P2X4-AAA (untagged). HindIII
and XhoI restriction sites were incorporated into the oligonucleotides
used for PCR ampliﬁcation (shown in bold, Table 1). The PCR product,Table 1
Oligonucleotide primers used to create P2X4R constructs. Sequences of the primers used to g
in bold text.
Forward Primer
P2X4-EG FP GACGGCAAGCTTATGGCGGGCTGCTGCTCCGTGCTCGG
P2X4-C-P2XI-EGFP GACGGCAACGTTGGCTCTGGAATTGGCATCTTTGGGGT
P2X4-Δ384-EGFP GACGGCAAGCTTATGGCGGGCTGCTGCTCCGTGCTCGG
P2X4-Δ378-EGFP GACGGCAAGCTTATGGCGGGCTGCTGCTCCGTGCTCGG
P2X4-AAA-EGFP GACGGCAAGCTTATGGCGGGCTGCTGCTCCGTGCTCGG
P2X4-AAA GACGGCAAGCTTATGGCGGGCTGCTGCTCCGTGCTCGGfollowing digestion was ligated into pCDNA3.1+ at the HindIII and
XholI sites (Invitrogen, Carlsbad, CA).
2.3. Transfection of DT-40 3KO/HEK-293 cells
Rat P2X4R constructs (P2X4-EGFP, P2X4-C-P2X1-EGFP, P2X4-Δ384-
EGFP, P2X4-Δ378-EGFP, and P2X4-AAA-EGFP) were transiently
transfected into DT-40 3KO cells using a Nucleofector System
(Amaxa, Gaithersburg, MD) following the manufacturer's instruc-
tions. Speciﬁcally, 5×106 cells were resuspended in 100 µL of Cell-line
Nucleofector Kit T solution andwere transfectedwith 5 µg of the P2XR
cDNA using Nucleofector program B-23. Experiments were performed
24 h after transfection. DT-40 3KO stable P2X4R expressing cells were
transiently co-transfected with either 5 µg of empty vector (Mock)
and 1 µg of pHcRed 1-N1 (red ﬂuorescent protein for visualization of
positively transfected cells) or 5 µg rat dynamin K44A (kindly
provided by Dr. Patricia Hinkle, University of Rochester) and 1 µg of
pHcRed 1-N1 using the procedure above.
P2X4R constructs were transiently transfected into HEK-293 cells
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) as described
previously [19,22]. Native P2XR constructs (non-EGFP tagged) were
co-transfected with 100 ng of pHcRed 1-N1 cDNA per well.
2.4. Creation of stable P2X4R-expressing DT-40 3KO and HEK-293 cells
NruI-digested plasmid (rat P2X4R in pcDNA3.1t) was introduced
into DT-40 3KO cells by nucleofection using program B-23 and
solution T as per the manufacturer's instructions (Amaxa, Gaithers-
burg, MD) to create the DT-40 3KO P2X4R stable cell line. After
nucleofection, the cells were incubated in growth medium for 24 h
prior to dilution in selection medium containing 2 mg/mL Geneticin
(Invitrogen, Carlsbad, CA). Wells exhibiting growth after the 7 day
selection period were picked for expansion. HEK-293 cells stably
expressing EGFP- tagged P2X4R were generated using Flp-recombi-
nase mediated integration. P2X4-EGFP (rat P2X4R in pEGFP-N3) was
digested in two steps with HindIII and NotI. This product was ligated
into pcDNA5/FRT (Invitrogen, Carlsbad, CA) at these sites. Flp-In 293
cells (Invitrogen, Carlsbad, CA)which harbor a single FRT sitewere co-
transfected with a 1:9 DNA ratio of P2X4-EGFP in pcDNA5/FRT vector
to pOG44 vector using Lipofectamine 2000 reagent. After 48 h,
expressing cells were selected with hygromycin B (200 μg/mL).
P2X4R expression was conﬁrmed in hygromycin B-resistant colonies
by the presence of EGFP ﬂuorescence and through tests of P2X4R
function as described.
2.5. Digital imaging of intracellular Ca2+
DT-40 3KO cells were used as a null background for P2XR [22].
These cells lack all three (3KO) inositol 1,4,5-trisphosphate receptors
(InsP3R) and thus negate any possible Ca2+ response as a conse-
quence of P2YR activation. DT-40 3KO cells were kindly provided by
Dr. Kurosaki (Kansai Medical University, Japan) [23] and maintained
as previously described [24–27]. DT-40 3KO cells were loaded withenerate P2X4R mutations are shown. Note that restriction enzyme sites are highlighted
Reverse Primer
GTCC TAGTTGGTCGACCTGGTTCATCTCCCCCGAAAGACCCTG
GGCC TAGTTGGTCGACGGATGTCCTCATGTTCTCCTGCAGGCCCAG
GTCC TCAGTCGACCGAAAGACCCTGCTCGTAGTCTTCCACATA
GTCC TCAGTCGACGTCTTCCACATACTTATATTTCTTGTCCCG
GTCC TACCGTCGACCTGGTTCATCTCCCCCGAAGCAGCCTGCTCGGCGT
GTCC TCACTCGAGTCACTGGTTCATCTCCCCCGAAGCAGCCTGCTC
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incubation for 15 min at room temperature (RT). Subsequently, cells
were removed from the Fura-2AM containing solution, and resus-
pended in a physiological saline solution used for imaging experi-
ments that contained (in mM): 137 NaCl, 0.56 MgCl2, 4.7 KCl, 1
Na2HPO4, 10 HEPES, 5.5 glucose, 1.26 CaCl2, pH 7.4. Fura-2 loaded cells
were allowed to adhere to a 25 mm glass coverslip for one minute
before cells were locally superfused at a rate of at least 1 mL/min
using a 0.5 mm diameter fused silica tube placed within 100 µm of theFig. 1. The forskolin-mediated enhancement of P2X4R signaling is blocked by PKA inhibition.
P2X4R protein can readily be detected after transient overexpression of the receptor (inse
−30 mV. (A) Treatment of P2X4R-transfected HEK-293 cells with 25 µM ATP resulted in an i
[19]. (B) Pretreatment with PKI, a cell-permeable PKA inhibitor, abolished the enhanced inw
forskolin-treated second current was not signiﬁcantly different in magnitude to previously
PKI/forskolin treatment, 66±16%, n=8 and n=4 respectively, p=0.59). However, there w
forskolin and previously published forskolin-treated values (P2X4R forskolin treatment, 45
and n=4 respectively, p=0.017 respectively). (C) [Ca2+]i signals mediated by ATP in DT-4
8-CPT-2′-O-Me-cAMP. In the same cells, forskolin treatment resulted in a signiﬁcant po
representative of three or more experiments.cells to be recorded. Rapid solution changes were accomplished
utilizing an solenoid controlled perfusion system and gravity fed
reservoirs (Warner Instruments, Hamden, CT). Imaging was per-
formed using an inverted epiﬂuorescence Nikon microscope with a
40× oil immersion objective lens (numerical aperture, 1.3). Fura-2
loaded cells were excited alternately with light at 340 and 380 nm
using a monochrometer-based illumination system, and the emission
at 510 nm was captured using a high speed, digital CCD camera (TILL
Photonics, Pleasanton, CA). The ﬂuorescence ratio of 340 nm/380 nmAn immunoblot of mock-transfected HEK-293 cells shows that they lack P2X4R, whereas
t). Transfected HEK-293 cells were whole cell patch clamped at a holding potential of
nward current, which was enhanced by forskolin, consistent with our previous ﬁndings
ard current following forskolin treatment in P2X4R-transfected HEK-293 cells. The PKI/
published control values (P2X4R control, 76±10% of initial response [19] versus P2X4R
as a signiﬁcant difference between the magnitude of the second response between PKI/
1±101% of initial response [19] versus P2X4R PKI/forskolin treatment, 66±16%, n=9
0 3KO cells stably expressing P2X4R were not modulated by the EPAC speciﬁc analog
tentiation of Ca2+ signals. The data are presented as the mean±S.E. Each trace is
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Images were acquired at a rate of 1 Hz with an exposure of 20 ms. All
imaging experiments were performed at RT, essentially as previously
described [19,28]. Traces are from a single cell, representative of
multiple individual cells in a particular experimental run, and n
represents the number of experimental runs, with at least 3 cells per
experimental run.
2.6. Whole cell patch clamp recordings
HEK-293 cells do not endogenously express P2X receptors. ATP-
activated cation currents in transfected cells were recorded at a
sampling rate of 1 kHz using an Axopatch 200A patch clamp ampliﬁer
(Axon Instruments, Union City, CA), Axon digital interface, and
pCLAMP version 9.0 software under whole cell patch clamp condi-
tions. To measure ATP-activated currents in HEK-293 cells, cells were
perfused with an extracellular solution containing (mM): 140 NaCl, 5
CsCl, 1.2 MgCl2, 1 CaCl2, 10 HEPES, 10 D-glucose, pH 7.4. Internal patchFig. 2. cAMP-mediated potentiation of ATP-mediated Ca2+ signals in DT-40 3KO cells and A
P2X4-EGFP was generated by tagging the C-terminus of P2X4R with EGFP. (A) Multiple resp
3KO cells transiently overexpressing P2X4-EGFP receptors. (C) Forskolin enhanced ATP-
representative of 4 or more experiments.solution contained (mM): 140 Cs-acetate, 1.22 MgCl2, 10 HEPES-
CsOH, 0.1 EGTA, 10 NaCl, 0.0365 CaCl2, pH 7.2. Intervals of 2–3 min
were allowed between patch rupture and stimuli to allow for
equilibration with the patch pipette solution. HEK-293 cells were
held at a holding potential of−30 mV. Experiments were performed
at room temperature.
2.7. Total internal reﬂectance microscopy
TIRF microscopy was performed essentially as previously de-
scribed [29]. Excitation light was provided by a 20 mWArgon Krypton
laser (Omnichrome 43 series Meles Griot, Carlsbad, CA). The laser was
directed through a light guide into a Till Photonics Polytrope TIRF
condenser attached to the rear port of the microscope and through
appropriate ﬁlters to select individual laser lines to a TIRF optimized
high NA oil immersion objective (Olympus, Plan APO ×60, 1.45 NA)
P2X4-EGFP was excited using the 488 nm line of the laser isolated
using a 488 nm band pass ﬁlter (BP 10 nm), 500 nm dichroic beamTP-activated currents in HEK-293 cells is retained in cells overexpressing P2X4-EGFP.
onses to ATP. (B) Forskolin treatment enhanced ATP-mediated Ca2+ signaling in DT-40
activated current in HEK-293 cells overexpressing P2X4-EGFP receptors. Traces are
Fig. 3. A chimeric P2X4R with a P2X1R C-terminus is not enhanced by raising cAMP. P2X4-C-P2X1-EGFP was generated using the N-terminal, ﬁrst transmembrane domain, and
extracellular regions from P2X4R and replacing the second transmembrane domain and C-terminus with the corresponding amino acids from P2X1R. (A) Transient transfection of
P2X4-C-P2X1-EGFP receptors into DT-40 3KO cells elicited a Ca2+ spike when stimulated with ATP, which was no longer enhanced by forskolin treatment. (B) Forskolin did not
enhance ATP-activated current in HEK-293 cells overexpressing chimeric P2X4-C-P2X1-EGFP receptors. Traces are representative of 4 or more experiments.
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band pass ﬁlter optimized for TIRF microscopy (BrightLine® series,
Semrock, Rochester, NY). Images were collected every 5–10 s using a
Cooke SensicamQE camera controlled by Till Vision imaging suite. The
laser was set to 50% power and angle of the beam was controlled
within the objective lens by means of a computer controlled
galvanometer driven mirror within the Polytrope. This TIRF angle
was established (and remained ﬁxed during the course of the studies)
by imaging 200 nm polystyrene beads coated with ﬂuorescent dye;
TIR was judged to be occurring when discrete ﬂuorescence of
stationary, adhered beads (“landmark” beads) plus the occasional
random “ﬂashes” of beads transiently settling on the cover-glass were
observed. TIRF microscopy was performed at 37 °C in a closed
environmental chamber (Precision Plastics Inc., Beltsville MD) on
the stage of an IX71 inverted microscope (Olympus, Center Valley,
PA.).
2.8. Statistical analysis
Statistical signiﬁcance was determined using unpaired t tests. Data
from several cells in a particular experimental run were averaged,
and experimental averages were used to calculate the mean±S.E.Table 2
Summary of mutant P2X4 receptors and cAMP-dependent regulation. Note that the presence
construct is enhanced by raising cAMP (shown by +) or not (shown by−).Two-tailed p values of less than 0.05 were considered statistically
signiﬁcant.
3. Results
3.1. cAMP-induced enhancement of P2X4 receptor signaling is blocked by
PKA inhibition
A previous study from our laboratory has demonstrated that
raising cAMP results in markedly augmented ATP-activated P2X4R
signaling. The detailed molecular mechanism underlying this phe-
nomenon was, however, not established [19]. An obvious posit to
account for the potentiation is that raising cAMP activates PKA and
either phosphorylates the P2X4R directly or alternatively an accessory
protein. To directly test if PKA activation is required for this
potentiation, we investigated if inhibition of PKA could abrogate the
enhanced signaling observed after raising cAMP [19]. Two systems
were chosen to serve as expression platforms to evaluate P2X4R
function in isolation: DT-40 chicken pre-B lymphocytes and HEK 293
cells. The former do not express any purinergic receptors, while the
latter are null for P2XR. Ca2+ signaling events were monitored in DT-
40 3KO cells and the channel activity was measured directly usingor absence of the endocytosis motif (highlighted in gray) corresponds with whether the
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transfection [19,22]. An immunoblot, Fig. 1 inset, conﬁrmed the lack
of P2X4R in mock-transfected HEK-293 cells, whereas P2X4R-
transfected HEK-293 cells displayed a single distinct band. Treatment
with forskolin signiﬁcantly enhanced the ATP-induced inward current
in P2X4R-expressing HEK-293 cells (Fig. 1A), in agreement with our
previously published ﬁndings [19]. Incubation with myristolylated
PKI6–22, a speciﬁc, cell-permeable PKA inhibitor [30], abolished this
potentiation (Fig. 1B). The second response after PKI and forskolin
treatment was 66±16%with respect to the initial stimulation (n=5).
This was not signiﬁcantly different from previously published control
responses without forskolin [19]. These data clearly demonstrate
that PKA activation is required for the observed effect. In further
support of this contention, H89, a non-selective serine/threonine
protein kinase inhibitor also abrogated the effect of PKA activation
(data not shown).
EPAC proteins represent an additional family of PKA-independent
cAMP effectors. Several lines of evidence make it unlikely that these
proteins regulate P2X4R signaling. First, regulation through EPAC
proteins is unaffected by PKA inhibition (29) and secondly, the EPAC
selective activator 8-CPT-2′-O-Me-cAMPwas unable to reproduce the
potentiation of Ca2+ signaling observed following PKA activation in
DT-40 cells stably expressing the P2X4R (Fig. 1C).
3.2. Deﬁning the region of the P2X4R required for PKA-dependent
enhancement
Next, a mutational strategy was employed to identify the speciﬁc
region of the P2X4R that was required for PKA-mediated potentiation.Fig. 4. cAMP-mediated potentiation of ATP-mediated Ca2+ signals in DT-40 3KO cells and AT
mutant receptor P2X4-Δ384-EGFP. P2X4-Δ384-EGFP was generated by removing the last 5
expressing this construct. (B) Forskolin treatment enhanced ATP-mediated Ca2+ signaling in
ATP-activated currents in HEK-293 cells overexpressing P2X4-Δ384-EGFP receptors. TracesThis approach was undertaken to reveal potential PKA phosphoryla-
tion sites, implicate potential binding partners, and provide key
insight into themechanism of the potentiation.Wild-type andmutant
receptors were tagged at the C-terminus with EGFP to facilitate
identiﬁcation of expressing cells and to validate the PM localization of
mutated receptors. The P2X4R-EGFP was functional, since multiple
exposures to ATP resulted in repetitive elevations in [Ca2+]i similar to
wild-type (Fig. 2A, 2nd response 85±7% of initial response, n=5). In
addition, forskolin treatment augmented the 2nd ATP-evoked Ca2+
signal in DT-40 3KO cells expressing P2X4R-EGFP (Fig. 2B, 232±43%
over the initial control response in the presence forskolin, n=5).
Furthermore, forskolin treatment increased ATP-evoked inward
currents in HEK-293 cells expressing P2X4R-EGFP (Fig. 2C, 156±
23% over the initial control response, n=4). These results are
summarized in Fig. 7A–B.
Both the N- and C-termini of P2X4R face the cytoplasm and thus
are potentially subject to modulation by cellular factors. Of particular
note, sequence analysis does not reveal any recognizable PKA
consensus phosphorylation sites based on the canonical RRXS/T or
RXXS/T motifs in either of these regions. The N-termini of P2XR are
fairly short (≤30 amino acids, 27 amino acids in P2X4R), and the C-
termini diverge in sequence and length considerably [2]. In addition,
P2X4R and P2X7R have high sequence similarity in the N-terminal
region, but P2X7R signaling is not affected by raising cAMP levels [19].
In total, this information indicates that the P2X4R N-terminus may not
be a promising candidate region subject to this regulation [18]. Thus,
initial mutational analysis was performed in the C-terminus. A
chimera in which the C-terminus of the P2X4R was substituted with
the C-terminus of the P2X1R (P2X4-C-P2X1-EGFP) was generated. TheP-activated currents in HEK-293 cells is retained in cells overexpressing the truncation
amino acids of the P2X4R C-terminus. (A) Multiple responses to ATP exposure in cells
DT-40 3KO cells overexpressing P2X4-Δ384-EGFP receptors. (C) Forskolin potentiated
are representative of 4 experiments.
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forms a hetero-channel with P2X4R subunits and thus would likely
yield a functional channel and secondly, because P2X1R signaling is
unaffected by PKA activation this chimera might reveal structural/
sequence requirements for the effect of PKA [2,13]. P2X4-C-P2X1R-
EGFP were expressed in either DT-40 3KO cells or HEK-293 cells and
similar experimental paradigms were used to those shown in Fig. 2.
Stimulation with ATP resulted in a Ca2+ transient or inward cation
current similar to cells expressing the P2X4-EGFP receptor. However,
treatment with forskolin did not enhance the ATP-mediated Ca2+
signals (Fig. 3A) or inward currents (Fig. 3B). The kinetics of the
currents in the chimera were different from the wild-type receptor,
but superﬁcially resembled the rapid desensitization kinetics of the
P2X1R [2]. These data suggest that PKA regulation of P2X4R is
dependent on determinants present in the C-terminus of P2X4R,
which are absent in the C-terminus of P2X1R.
3.3. P2X4R truncations reveal an important region in the C-terminus
required for PKA-mediated regulation
To further deﬁne the regions important for PKA regulation in the
C-terminus, two P2X4R C-terminal truncations were generated (see
Table 2). The effect of PKA activation was retained in a construct
designated P2X4-Δ384-EGFP where the terminal 5 amino acids
were removed from the receptor (Fig. 4A–C). In DT-40 3KO cells the
2nd Ca2+ response in the absence of forskolin was 60±4% (n=11) of
the initial challenge (Fig. 4A), while treatment with forskolin
signiﬁcantly enhanced the Ca2+ signal (Fig. 4B, 311±55% over the
initial control response, n=4). Furthermore, the ATP-induced inward
current in HEK-293 cells expressing P2X4-Δ384-EGFP was also
increased following exposure to forskolin (Fig. 4C, 158±42% over
the initial control response, n=4). In comparison, the 2nd ATP-Fig. 5. Truncation of 11 amino acids in the P2X4R C-terminus prevents cAMP-mediated poten
11 amino acids of the P2X4R C-terminus. (A) Multiple responses to ATP exposure in cells e
signaling in DT-40 3KO cells overexpressing P2X4-Δ378-EGFP receptors. (C) Forskolin did n
receptors. Traces are representative of 5 or more experiments.evoked current in HEK-293 cells in the absence of forskolin was 77±
12% (n=3) of the initial response. The effect of PKA observed in this
construct was not signiﬁcantly different from that observed in cells
expressing the wild-type P2X4R-EGFP (see data summary Fig. 7A–B,
p=0.29 and p=0.97 respectively).
A more extensive truncation, where a total of 11 amino acids were
removed from the receptor designated P2X4-Δ378-EGFP, was how-
ever not regulated following PKA activation. As shown in Fig. 5A–C,
PKA activation did not increase either Ca2+ signals in DT-40 3KO cells
(Fig. 5A–B, 69±6% (n=9) over initial control in the absence of
forskolin and 52±4% (n=5) following exposure to forskolin) or the
inward current in HEK-293 cells (Fig. 5C, 64±8% (n=3) over initial
control in the absence of forskolin and 55±13% (n=6) following
exposure to forskolin). Of note, deletion of these additional amino
acids removed a putative tyrosine based sortingmotif (YEQGL), which
has been implicated in P2X4R trafﬁcking out of the PM [31,32].
It is known that P2X4R constitutively internalize and then recycle
back to the surface PM [33]. This cycling was proposed to be a
mechanism for rapidly regulating the functional expression of
receptors. Agonist application (100 μM ATP for 15 min) has been
shown to increase the internalized fraction of P2X4R by approximately
60%, consistent with ﬁndings published on P2X1R [33,34]. The YXXGL
motif has been reported to be required for receptor internalization and
recognition by the adapter protein 2 (AP2) complex and disruption of
this motif results in decreased internalization and enhanced surface
expression [31].
3.4. PKA regulation of P2X4R requires an intact YXXGL motif in the C-
terminus
To determine if this motif was important for regulation of P2X4R by
PKA, a full length receptormutantwas generatedwith only the YXXGLtiation of ATP-mediated signaling. P2X4-Δ378-EGFP was generated by removing the last
xpressing this construct. (B) Forskolin treatment did not enhance ATP-mediated Ca2+
ot augment ATP-activated currents in HEK-293 cells overexpressing P2X4-Δ378-EGFP
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receptor to yield AXXAA at amino acids 378–382. The effect of PKA
regulation on this mutant was not present in DT-40 3KO cells (57±5%
of the initial response in the absence (Fig. 6A, n=6) or 43±12% over
the initial response in the presence of forskolin (Fig. 6B, n=7))
Similarly, the effect of PKA activation was eliminated in HEK-293 cells
expressing this construct (46±10% over the initial control response,
Fig. 6C, (n=9)). These data are similar to those obtained in cells
expressing the P2X4-Δ378-EGFP construct shown in Fig. 5A–C, which
also had this motif disrupted (see data summary Fig. 7A–B, p=0.56
and p=0.59 respectively). An amino acid alignment of the C-terminus
of the mutants is shown in Table 2, which demonstrates the absolute
requirement for the YXXGL endocytosis motif to be intact for cAMP-
mediated enhancement to occur (highlighted in gray).
Importantly, this mutational analysis also argues against direct
P2X4R phosphorylation by PKA, since as previously noted there are no
PKA consensus sites in regions required for the functional effect. In
fact, there is only one serine residue present in the entire intracellular
C-terminal region at position 383 (not a PKA consensus site (QGLS)).
In support of this mutational and sequence analysis, extensive efforts
to detect direct P2X4R phosphorylation by PKAwere unsuccessful. For
example, both in vivo and in vitro attempts to demonstrate phos-
phorylation of P2X4R failed under conditions were phosphorylation of
known PKA substrates could be clearly shown (Supplemental Fig. 1).
These data strongly suggest that, while PKA activation is absolutely
required, the potentiation of P2X4R signaling does not involve direct
phosphorylation of the receptor. In addition, mutational analysisFig. 6. Disruption of the YXXGL endocytosis motif in the full length P2X4R also prevents cAM
three alanine point mutations in the YXXGL motif of the full length P2X4R. (A) Multiple respo
enhance ATP-mediated Ca2+ signaling in DT-40 3KO cells overexpressing P2X4-AAA-EGF
overexpressing P2X4-AAA-EGFP receptors. Traces are representative of 6 or more experimesuggests that the target of PKA is a protein which interacts with the
putative tyrosine based sorting motif.
3.5. PKA activation results in accumulation of P2X4-EGFP near the
plasma membrane
A HEK-293 cell line was created which stably expressed P2X4-
EGFP. We next performed TIRF microscopy to monitor the movement
of tagged receptors in the vicinity of the PM. The evanescent ﬁeld
established following TIR allows the excitation of ﬂuorophores within
125–175 nm of the PM. Following establishment of TIR, the
ﬂuorescence of P2X4-EGFP was manifested as discrete ﬂuorescent
puncta (contrast wide-ﬁeld image and TIRF image in Fig. 8A). Under
resting conditions, a signiﬁcant proportion of these puncta were
mobile and moved apparently randomly in and out of the evanescent
ﬁeld. Following forskolin treatment, the puncta appeared to coalesce
and be retained for extended periods of time in larger areas as shown
in representative images (Fig. 8B) and kinetic line plots (Fig. 8C) for 3
areas indicated in the gray scale image (Fig. 8B). This accumulation of
ﬂuorescence did not occur as a function of morphological changes
in HEK cells initiated by PKA because a membrane targeted YFP
(myr-YFP) did not similarly accumulate in large puncta following PKA
activation (data not shown). Further experiments were performed in
which TIRF ﬂuorescence wasmonitored in cells transiently expressing
P2X4-AAA-EGFP (Fig. 8D). In contrast to P2X4-EGFP expressing cells,
no increase in near-PM ﬂuorescence was observed in these cells
following forskolin exposure. These data indicate that P2X4R areP-mediated potentiation of ATP-mediated signaling. P2X4-AAA-EGFP was generated by
nses to ATP exposure in cells expressing this construct. (B) Forskolin treatment did not
P receptors. (C) Forskolin did not enhance ATP-activated currents in HEK-293 cells
nts.
Fig. 7. Data summary of ATP-mediated Ca2+ signals in DT-40 3KO cells and ATP-
activated currents in HEK-293 cells overexpressing P2X4R mutants. (A) Data summary
of ATP-mediated Ca2+ signaling in DT-40 3KO cells from paired experiments, where the
forskolin-treated second response is expressed as a percentage of the control-treated
ﬁrst response (white bar graph). (B) Data summary of ATP-activated currents in HEK-
293 cells from paired experiments, where the forskolin-treated second response is
expressed as a percentage of the control-treated ﬁrst response (black bar graph). The
data are presented as the mean±S.E. (*, p<0.05).
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this is consistent with the proposal that this may contribute to the
augmentation of purinergic signaling following PKA treatment.
Nevertheless, attempts to demonstrate biochemically that P2X4R
accumulated at the PM following forskolin treatment using a
biotinylation paradigm were unsuccessful. The reason for this is
unclear, but may reﬂect the difﬁculties in detecting changes by this
technique of only a subpopulation of a proteinwhich is itself expressed
in relatively low abundance.
3.6. Dominant-negative dynamin K44A blocks forskolin-mediated
potentiation of P2X4R signaling
A complimentary approach was utilized to determine if the
forskolin-induced enhancement of P2X4R signaling involves endocy-
tosis through the sorting motif. In addition to mutating the
endocytosis motif on the P2X4R, the requirement for the interaction
of the P2X4R with the endocytosis machinery per se was tested.
Experiments were performed using a dominant-negative mutant
dynamin construct (dynamin K44A), which is not capable of
clatherin/AP2 mediated endocytosis [35]. DT-40 3KO cells stably
expressing wild-type P2X4R were utilized to maintain similar P2X4R
expression levels between different experiments. Stable P2X4R
expressing cells were then either co-transfected with empty vector
(Mock) and HcRed (for positive identiﬁcation of transfected cells) or
dynamin K44A and HcRed. There was a trend for dynamin K44A
transfected cells to exhibit an increased ATP-mediated Ca2+ response,
however the Ca2+ responses were not statistically different from
mock-transfected cells (Mock; 0.13±0.05 ratio units over baseline
versus K44A; 0.33±0.13, n=17 and n=11 respectively, p=0.14),suggesting dynamin K44A enhanced P2X4R surface expression. These
ﬁndings are consistent with experiments that demonstrated en-
hanced ATP-mediated P2X4R current amplitudes when using either
dominant-negative μ2 (also called AP-50) subunits from the AP2
complex or dominant-negative Esp15, which interacts with the AP2
complex [36]. Dominant-negative μ2 subunits have also been
reported to increase P2X4R surface expression [31]. Mock-transfected
DT-40 3KO cells stably expressing P2X4R still exhibited signiﬁcantly
augmented ATP-mediated Ca2+ signals following forskolin treatment
(Fig. 9A+C, Mock control treatment; 96±6% of 1st response versus
Mock forskolin treatment; 190±23% of 1st response, n=4 and
n=13 respectively, p=0.04). However, expression of dominant-
negative dynamin K44A in DT-40 3KO cells stably expressing P2X4R
resulted in ATP-mediated Ca2+ signals that were not augmented
following forskolin treatment (Fig. 9B). This result was signiﬁcantly
different from mock-transfected cells (Fig. 9C, Mock forskolin
treatment; 190±23% of 1st response versus K44A forskolin treat-
ment; 114±18% of 1st response, n=13 and n=8 respectively,
p=0.03). In fact, forskolin treatment had no signiﬁcant effect over
control treatment when dynamin K44A was expressed (Fig. 9C, K44A
control treatment; 97±20% of 1st response versus K44A forskolin
treatment; 114±18% of 1st response, n=3 and n=8 respectively,
p=0.61).
TIRF experiments were next performed to corroborate the above
data that expression of dominant-negative K44A dynamin elimi-
nated the effects of forskolin treatment by disrupting trafﬁcking to/
from the PM. HEK-293 cells stably expressing P2X4R-EGFP were
transiently transfected with cDNA encoding K44A dynamin and
HcRed to positively identify transfected cells. Fig. 10 illustrates a
representative experiment typical of 6 others from 3 transfections.
Fig. 10A shows a bright ﬁeld image of a group of cells (Fig. 10Ai), a
number of which express HcRed and thus presumably K44A dynamin
(Fig. 10Aii). As measured by HcRed ﬂuorescence a range of ex-
pression was noted, but ∼70% of cells expressed detectable
ﬂuorescence. P2X4R-EGFP ﬂuorescence observed by conventional
ﬂuorescence microscopy was clearly visualized in the PM as well as
in intracellular compartments (Fig. 10Aiii). Under TIRF conditions,
as shown previously, isolated ﬂuorescent puncta were evident,
representing points of close apposition of the PM to the coverslip
(Fig. 10Aiv). In cells expressing prominent HcRed ﬂuorescence
(>500 gray levels) the intensity of P2X4R-EGFP TIRF ﬂuorescence
often appeared brighter than in neighboring cells with less HcRed
ﬂuorescence (arrow in Fig. 10Aii and 10Aiv). In contrast to control
conditions (Fig. 8), the puncta observed in these experiments ap-
peared relatively immobile as can be seen in representative images
captured over many minutes (Fig. 10Ba–e) Importantly, the dis-
tribution and size/intensity of the puncta was unaltered by forskolin
treatment (Fig. 10B–C). These data are consistent with expression of
dominant-negative dynamin leading to accumulation of P2X4R-EGFP
in the plasma membrane as a result of attenuated endocytosis and
further that inhibition of the trafﬁcking machinery effectively
eliminates the effects of forskolin to increase the amount of P2X4R
close to the PM. In summary, mutation of the P2X4R sorting motif or
disruption of the endocytosis machinery is sufﬁcient to prevent PKA-
mediated potentiation of P2X4R signaling and thus strongly suggests
that the underlying mechanism involves modulation of endocytotic
machinery.
4. Discussion
This study reports that PKA-mediated regulation of P2X4R
signaling requires the internalization motif YXXGL. A likely explana-
tion is that raising cAMP can inhibit constitutive endocytosis resulting
in an increase in the number of functional P2X4R at the PM. Because
the YXXGL motif on P2X4R can interact with the μ2 subunit of the AP2
complex, possible targets for PKA may include proteins in this
Fig. 8. PKA activation increases the number of P2X4-EGFP in the vicinity of the plasma membrane. Experiments were performed monitoring the movement of P2X4-EGFP using TIRF
microscopy in cells stably expressing the receptor. (A) Shows the ﬂuorescence of P2X4-EGFP in wide ﬁeld (WFM) and following establishing TIRF mode (TIRFM). (B) Shows a series
of images obtained at the time-points indicated in (C) for a group of HEK-293 cells stably expressing P2X4-EGFP. (C) Shows kinetic plots from 3 regions of interest indicated in the
gray scale image in (B). Following forskolin treatment ﬂuorescence puncta grew larger and increased intensity. An exemplar experiment showing three regions of interest typical of
data from 7 experimental runs. (D) Shows similar experiments in which P2X4-AAA-EGFP was transiently expressed in cells. Forskolin treatment did not alter the distribution of this
mutant receptor.
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Fig. 9. DT-40 3KO cells stably expressing P2X4R exhibit forskolin-mediated enhancement of ATP-evoked Ca2+ signals, which can be blocked by dominant-negative dynamin K44A
expression. (A) ATP-activated Ca2+ signals in mock-transfected DT-40 3KO cells stably expressing P2X4R are enhanced by forskolin treatment. (B) Forskolin treatment had no effect
on ATP-mediated Ca2+ signals in DT-40 3KO cells stably expressing P2X4R and transiently overexpressing dominant-negative dynamin K44A. Traces are representative of eight or
more experiments. (C) Data summary of ATP-mediated Ca2+ signaling in DT-40 3KO cells stably expressing P2X4R from paired experiments after transient mock- or dynamin K44A-
transfection (white and black bar graph, respectively), where the control- or forskolin-treated second response is expressed as a percentage of the control-treated ﬁrst response.
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phosphorylated on a threonine residue [37]. In addition to μ2, the AP2
complex also contains α and β2 subunits, both of which have been
shown to be phosphorylated in vivo [38]. Future experiments are
necessary to identify the protein(s) involved in this novel PKA
potentiation mechanism of P2X4R signaling.
Data in the present study supports the notion that PKA activity
increases the amount of functional P2X4R at the PM through an effect
on the endocytosis machinery. However, the possibility of an effect on
the receptor at the single channel level, resulting in an increase in the
single channel conductance (i(cation)) and/or the open probability
(Po), cannot be excluded. In support of this idea, ivermectin, in
addition to causing an increase in surface expression of P2X4R, has
also been shown to modulate P2X4R single channel conductance and
open probability [36,39].
The work presented in this study adds to a growing body of
literature that suggests that protein kinase regulation of P2X receptors
does not involve direct receptor phosphorylation. Vial et al. were the
ﬁrst to suggest that PKC-mediated modulation of P2X1R did not
involve direct receptor phosphorylation [40]. We recently demon-
strated that PKC-mediated modulation of P2X3R signaling does not
result from direct receptor phosphorylation [22]. This study now
presents evidence that PKA regulation of P2X4R is unlikely to involve
direct receptor phosphorylation. In total, these data lend support to a
common themewhereby protein kinasemodulation of P2XR signaling
involves accessory proteins. Further study is necessary to ascertainwhether common central mechanisms are involved in phosphoregu-
lation of P2XR in general.
The major ﬁnding of this study, that PKA activation can
signiﬁcantly enhance P2X4R-mediated signaling could have broad
physiological consequences in tissues with predominant expression
of these receptors given that PKA activation is the end point of a
ubiquitous signaling system. For example, in salivary acinar cells Ca2+
ﬂux through P2X4R only generates a minimal cytosolic Ca2+ signal in
absence of PKA activation [19]. Strikingly as cAMP is elevated, whole
cell current through the channel and the resultant Ca2+ change are
markedly increased [19]. These Ca2+ signals would be predicted to
signiﬁcantly increase both ﬂuid and protein secretion from the gland
under these conditions. Since parasympathetic and sympathetic co-
stimulation of the gland is the usual physiological situation, this form
of regulation in all probability should be considered the norm. Other
examples where this mode of modulation may be signiﬁcant include
bronchiolar epithelium were P2X4R are abundant and play a key role
inmaintaining the beating of cilia required tomove themucus layer to
clear airways [41]. Augmented Ca2+ entry following sympathetic
input through P2X4R could conceivably be of therapeutic beneﬁt in
situations such as cystic ﬁbrosis where mucus accumulates and is
slowly cleared [41]. P2X4R−/− mice are hypertensive [42]. It is
possible that phosphoregulation of P2X4R could also play a role in
the regulation of blood pressure. For example, enhanced [Ca2+] as a
consequence of increased P2X4R activity in the endothelium of
the vasculature could increase nitric oxide release, resulting in
Fig. 10. Expression of dominant-negative K44A dynamin eliminates the forskolin-induced retention of P2X4-EGFP close to the PM. (Ai) Bright ﬁeld image of HEK-293 cells stably
expressing P2X4-EGFP and transiently co-expressing HcRed and K44A dynamin. (Aii) Wide-ﬁeld ﬂuorescence image indicating HcRed expression (Ex 560 nm; Em>600 nm).
(Aiii) Wide-ﬁeld ﬂuorescence image of P2X4-EGFP (Ex 488 nm; Em 510 nm). (Aiv) TIRF ﬂuorescence image of P2X4-EGFP. (B) Series of TIRF images captured at the time-points
indicated in C in which the cells were exposed to forskolin. (C) Kinetic line plot of average ﬂuorescence from the red box shown in B.
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help increase our understanding of neuropathic pain, as P2X4R are
involved in deranged sensory transduction observed in tactile
allodynia, a condition where intense pain is generated from light
touches of the skin that were previously innocuous [42].
In summary, PKA-mediated modulation of the P2X4R requires an
intact YXXGL endocytosis motif in the C-terminus. Mutational analysis
of this region suggests that this regulation does not involve P2X4R
phosphorylation. Instead, the mechanism of potentiation appears to
involve regulation of the endocytosis pathway, since it can be blocked
by disruption of either the endocytosis motif on the receptor or the
endocytosis machinery. PKA-mediated inhibition of endocytosis could
increase the number of P2X4R at the PM, hence increasing the effects
of subsequent ATP stimulation. Finally, these data highlight the
importance of accessory proteins in the regulation and modulation of
ion channels. Further studies will be necessary to identify these
accessory proteins.
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